-
1
-
-
77954179995
-
Statins and all-cause mortality in highrisk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65, 229 participants
-
Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in highrisk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65, 229 participants. Arch Intern Med. 2010;170(12):1024-1031.
-
(2010)
Arch Intern Med.
, vol.170
, Issue.12
, pp. 1024-1031
-
-
Ray, K.K.1
Seshasai, S.R.2
Erqou, S.3
-
2
-
-
79952052016
-
Statins for the primary prevention of cardiovascular disease
-
Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011; (1): CD004816.
-
(2011)
Cochrane Database Syst Rev.
, Issue.1
-
-
Taylor, F.1
Ward, K.2
Moore, T.H.3
-
3
-
-
74949136266
-
Optimizing statin treatment for primary prevention of coronary artery disease
-
Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S. Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med. 2010;152(2):69-77.
-
(2010)
Ann Intern Med.
, vol.152
, Issue.2
, pp. 69-77
-
-
Hayward, R.A.1
Krumholz, H.M.2
Zulman, D.M.3
Timbie, J.W.4
Vijan, S.5
-
4
-
-
67651111687
-
Lipid treatment assessment project 2: A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals
-
Lipid Treatment Assessment Project 2 Investigators
-
Waters DD, Brotons C, Chiang CW, et al; Lipid Treatment Assessment Project 2 Investigators. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009;120(1):28-34.
-
(2009)
Circulation
, vol.120
, Issue.1
, pp. 28-34
-
-
Waters, D.D.1
Brotons, C.2
Chiang, C.W.3
-
5
-
-
13444287861
-
National study of physician awareness and adherence to cardiovascular disease prevention guidelines
-
Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499-510.
-
(2005)
Circulation
, vol.111
, Issue.4
, pp. 499-510
-
-
Mosca, L.1
Linfante, A.H.2
Benjamin, E.J.3
-
6
-
-
2342565864
-
Drug treatment of hyperlipidemia in women
-
Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004;291(18):2243-2252.
-
(2004)
JAMA
, vol.291
, Issue.18
, pp. 2243-2252
-
-
Walsh, J.M.1
Pignone, M.2
-
7
-
-
4444382862
-
Pharmacologic lipidlowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians
-
American College of Physicians
-
Vijan S, Hayward RA; American College of Physicians. Pharmacologic lipidlowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med. 2004;140(8):650-658.
-
(2004)
Ann Intern Med.
, vol.140
, Issue.8
, pp. 650-658
-
-
Vijan, S.1
Hayward, R.A.2
-
8
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
-
CARDS investigators
-
Colhoun HM, Betteridge DJ, Durrington PN, et al; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696.
-
(2004)
Lancet
, vol.364
, Issue.9435
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
|